Under the FDA-authorized expanded access (IND 176297), urcosimod is being provided by OKYO Pharma for use in a patient with severe neuropathic corneal pain who has limited therapeutic options and no ...
Acanthamoeba keratitis is a rare but blinding parasitic eye disease. Experts share how to avoid it and treat it.
Signs and symptoms of ocular surface disease could be significantly reduced within 4 days after treatment with shelf-stable ...
A first-in-human pilot trial suggests umbilical cord–derived mesenchymal stem cell eye drops may safely improve symptoms and inflammation in refractory dry eye, including Sjögren’s syndrome.
Dry eye disease (DED) is one of the most common ocular surface disorders. All DED involves an imbalance between tear production and evaporation. Most cases of DED are driven by excessive evaporation, ...
Jai G. Parekh, MD, MBA; and Alexander Kabiri, OD; explore the current treatment landscape of dry eye disease. This is a video synopsis/summary of a Stakeholder Summit involving: Ryan Haumschild, ...
Please provide your email address to receive an email when new articles are posted on . Thyroid eye disease treatments have evolved significantly in recent years. Work is still needed to find durable, ...
Four years ago, Carolyn Adelsten woke up feeling like something was in her eye and it wouldn’t come out. She visited an eye specialist, got a diagnosis of mild dry eye disease and was told to use ...
Experts have warned that cases of this disease will rise to 1.6m in the UK by 2060 amid 'demographic timebomb' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback